Search research articles
Contact Us
Filters
Showing results (21-30 of 142) with videos related to
Page
of 15
Sort By:
Pharmacology & Therapeutics
|
June 25, 2013
Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma
Marc Tänzer, Magdalena Liebl, Michael Quante
Scandinavian Journal of Gastroenterology
|
August 12, 2009
Reply to the comment on "atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?" by Matsushita et al
Michael Quante, Hui Zhou, Tilman Sauerbruch
Best Practice & Research. Clinical Gastroenterology
|
May 12, 2021
The complexity of cancer origins at the gastro-oesophageal junction
Jan Bornschein, Michael Quante, Marnix Jansen
The American Journal of Gastroenterology
|
February 1, 2022
Endoscopic R1/Rx Resection of T1 Colorectal Cancer-What Next?
Arthur Schmidt, Hannes Philipp Neeff, Michael Quante
Gastroenterology
|
October 18, 2017
Insights Into the Pathophysiology of Esophageal Adenocarcinoma
Michael Quante, Trevor A Graham, Marnix Jansen
Deutsche Medizinische Wochenschrift (1946)
|
April 3, 2020
[Barrett Esophagus - Update of clinical management and therapy options]
Michael Quante, Julia Slotta Huspenina, Mohamed Abdelhafez
Small Gtpases
|
July 27, 2016
Functional implication of Dclk1 and Dclk1-expressing cells in cancer
C Benedikt Westphalen, Michael Quante, Timothy C Wang
Gut
|
April 2, 2022
Adenocarcinoma of the oesophagus: is it gastric cancer?
Michael Quante, Timothy C Wang, Adam J Bass
Virchows Archiv : an International Journal of Pathology
|
March 4, 2018
The metaplastic mosaic of Barrett's oesophagus
Sujata Biswas, Michael Quante, Simon Leedham, et al.
Gastroenterology
|
August 28, 2013
The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg?
Michael Quante, Julian A Abrams, Timothy C Wang
Page
of 15
Search research articles
Search
Showing results (21-30 of 142) with videos related to
Sort By:
Page
of 15
Pharmacology & Therapeutics
|
June 25, 2013
Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma
Marc Tänzer, Magdalena Liebl, Michael Quante
Scandinavian Journal of Gastroenterology
|
August 12, 2009
Reply to the comment on "atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?" by Matsushita et al
Michael Quante, Hui Zhou, Tilman Sauerbruch
Best Practice & Research. Clinical Gastroenterology
|
May 12, 2021
The complexity of cancer origins at the gastro-oesophageal junction
Jan Bornschein, Michael Quante, Marnix Jansen
The American Journal of Gastroenterology
|
February 1, 2022
Endoscopic R1/Rx Resection of T1 Colorectal Cancer-What Next?
Arthur Schmidt, Hannes Philipp Neeff, Michael Quante
Gastroenterology
|
October 18, 2017
Insights Into the Pathophysiology of Esophageal Adenocarcinoma
Michael Quante, Trevor A Graham, Marnix Jansen
Deutsche Medizinische Wochenschrift (1946)
|
April 3, 2020
[Barrett Esophagus - Update of clinical management and therapy options]
Michael Quante, Julia Slotta Huspenina, Mohamed Abdelhafez
Small Gtpases
|
July 27, 2016
Functional implication of Dclk1 and Dclk1-expressing cells in cancer
C Benedikt Westphalen, Michael Quante, Timothy C Wang
Gut
|
April 2, 2022
Adenocarcinoma of the oesophagus: is it gastric cancer?
Michael Quante, Timothy C Wang, Adam J Bass
Virchows Archiv : an International Journal of Pathology
|
March 4, 2018
The metaplastic mosaic of Barrett's oesophagus
Sujata Biswas, Michael Quante, Simon Leedham, et al.
Gastroenterology
|
August 28, 2013
The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg?
Michael Quante, Julian A Abrams, Timothy C Wang
Page
of 15